Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02998151 · ClinicalTrials.gov registry record · Early Phase 1
Neurophysiological and Acute Pharmacological Studies in FXS Patients
A Early Phase 1 study of Fragile X Syndrome, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT02998151 is a Early Phase 1 study of Fragile X Syndrome that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 29 participants, below the 100-participant average among 16 other Fragile X Syndrome trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02998151, a Early Phase 1 study of Fragile X Syndrome, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to utilize neurophysiologic assessments, behavioral measures and clinical measures to assess how much deficits associated with Fragile X Syndrome from pre-dose to post-dose using pharmacology.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Acamprosate
- DRUG Minocycline
- DRUG Lovastatin
- DRUG Baclofen
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2016-01 |
| Est. Completion | 2020-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02998151
The ClinicalTrials.gov registry entry for NCT02998151 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 16 other Fragile X Syndrome trials with a reported enrollment target (71% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fragile X Syndrome appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT02998151 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02998151 about?
NCT02998151 is a clinical study titled "Neurophysiological and Acute Pharmacological Studies in FXS Patients". The aim of this study is to utilize neurophysiologic assessments, behavioral measures and clinical measures to assess how much deficits associated with Fragile X Syndrome from pre-dose to post-dose using pharmacology.
What is the current status of trial NCT02998151?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 29 participants. The study started on 2016-01. Estimated completion is 2020-11.
What conditions does trial NCT02998151 study?
This clinical trial studies the following conditions: Fragile X Syndrome.
What interventions are being tested in trial NCT02998151?
The interventions under investigation include: Placebo (DRUG), Acamprosate (DRUG), Minocycline (DRUG), Lovastatin (DRUG), Baclofen (DRUG).
Who is sponsoring clinical trial NCT02998151?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02998151 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fragile X Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Infant
RECRUITING · NA
-
Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
RECRUITING · NA
-
Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG-Preschool Age
RECRUITING · NA
-
Speech-in-noise Perception in Autism and Fragile X
RECRUITING · NA
-
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.